Access Reimbursement Manager- Miami, FL at Acadia Pharmaceuticals

Miami, Florida, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, HealthcareIndustries

Requirements

Bachelor’s degree required; advanced degree or certification in healthcare-related fields is a plus
Minimum of 5 years of experience in access and reimbursement, patient support services, or pharmaceutical field roles
Knowledge of pharmacy benefit structures, reimbursement processes, and specialty pharmacy networks
Experience in Hepatology, Gastroenterology is preferred
Strong interpersonal and communication skills, with the ability to build relationships and provide exceptional customer service
Proven ability to work independently, prioritize tasks, and adapt to a fast-paced environment
50-60% Travel required within the assigned territory
Expertise in access and reimbursement, including payer policies and processes
Strong presentation and training skills, with the ability to explain complex concepts in a clear and concise manner

Responsibilities

Work directly with HCP offices to provide expertise on access and reimbursement challenges, including benefits investigation, prior authorizations, appeals, and financial assistance
Partner with healthcare providers to ensure patients have timely access to prescribed therapy by addressing access issues proactively
Educate healthcare providers and their staff on payer-specific policies, coverage criteria, and reimbursement processes for the specialty product
Conduct in-service programs and provide resources to help practices navigate access challenges effectively
Act as a liaison between the field team and internal stakeholders, providing insights on regional access trends and challenges
Collaborate with trade, market access, sales, patient support services, and analytics teams to ensure alignment and support for practices
Identify and resolve access barriers through collaboration with payers, specialty pharmacies (SPs), and other key stakeholders
Escalate unresolved issues to appropriate teams, ensuring timely resolution and communication back to providers
Leverage data and analytics tools to identify access trends, prioritize efforts, and report progress to leadership
Maintain accurate records of activities and interactions with practices to ensure compliance and track outcomes

Skills

benefits investigation

prior authorizations

appeals

financial assistance

patient access

reimbursement

access and reimbursement

pharmacy benefit

specialty product

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free